» Authors » Kenshi Yamasaki

Kenshi Yamasaki

Explore the profile of Kenshi Yamasaki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 139
Citations 3245
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Suzuki N, Kojima K, Malvica S, Yamasaki K, Chikamatsu Y, Oe Y, et al.
Commun Med (Lond) . 2025 Jan; 5(1):3. PMID: 39757253
Background: Chronic kidney disease (CKD) causes progressive and irreversible damage to the kidneys. Renal biopsies are essential for diagnosing the etiology and prognosis of CKD, while accurate quantification of tubulo-interstitial...
2.
Yamamoto T, Yamanaka K, Yamasaki K, Isaji H, Matsubara N, Hozawa H, et al.
J Dermatol . 2024 Nov; 52(2):270-280. PMID: 39535411
Pyoderma gangrenosum (PG) is a rapidly progressive disease characterized by deep ulcers, predominantly in the lower extremities. Adalimumab, a monoclonal antibody against tumor necrosis factor alpha, is the first drug...
3.
Kawaguchi C, Ozawa M, Hidaka T, Murakami K, Ishikuro M, Ueno F, et al.
Allergol Int . 2024 Oct; PMID: 39426877
Background: Precise skin phenotypic data are indispensable in accurately diagnosing atopic dermatitis (AD). Therefore, this study examined the interobserver concordance for AD and non-AD diagnoses between two dermatologists. AD prevalence...
4.
Tedasen A, Chiabchalard A, Tencomnao T, Yamasaki K, Majima H, Phongphithakchai A, et al.
Antioxidants (Basel) . 2024 Jun; 13(6). PMID: 38929152
Melanin, the pigment responsible for human skin color, increases susceptibility to UV radiation, leading to excessive melanin production and hyperpigmentation disorders. This study investigated the ethanolic extract of fruits for...
5.
Songsri J, Chatatikun M, Wisessombat S, Mala W, Phothaworn P, Senghoi W, et al.
J Infect Public Health . 2024 May; 17(7):102438. PMID: 38820898
Background: Burkholderia pseudomallei, a Gram-negative pathogen, causes melioidosis. Although various clinical laboratory identification methods exist, culture-based techniques lack comprehensive evaluation. Thus, this systematic review and meta-analysis aimed to assess the...
6.
Chatatikun M, Tedasen A, Pattaranggoon N, Palachum W, Chuaijit S, Mudpan A, et al.
PeerJ . 2023 Nov; 11:e16494. PMID: 38025738
Tyrosinase is a key enzyme in melanogenesis and its inhibitors have become increasingly because of their potential activity as hypopigmenting agents which have less side effects. Nipa palm vinegar is...
7.
Terui H, Segawa Y, Otake E, Omori R, Tsuchiyama K, Kikuchi K, et al.
J Dermatol . 2023 Aug; 51(1):e26. PMID: 37641893
No abstract available.
8.
Hayashi N, Ikeda M, Liu J, Raymundo E, Liu Y, Sasaki T, et al.
Dermatol Ther (Heidelb) . 2023 Jun; 13(8):1817-1830. PMID: 37356075
Introduction: Upadacitinib, an oral selective Janus kinase (JAK) inhibitor, is used to treat moderate-to-severe atopic dermatitis (AD). Acne is the most common treatment-emergent adverse event in patients with AD treated...
9.
Yamamoto T, Yamasaki K, Yamanaka K, Komine M, Kawakami T, Yamamoto O, et al.
J Dermatol . 2023 Jun; 50(9):e253-e275. PMID: 37311717
Pyoderma gangrenosum (PG) is a rare, neutrophilic skin disease. For the purpose of accurate diagnosis and proper treatment of PG, the Japanese clinical practice guidance for PG developed by the...
10.
Terui H, Segawa Y, Otake E, Omori R, Tsuchiyama K, Kikuchi K, et al.
J Dermatol . 2023 Jun; 50(11):1478-1483. PMID: 37269150
Palmoplantar pustulosis (PPP) is a chronic skin inflammatory disease characterized by sterile pustules on the palms and soles. Pustulotic arthro-osteitis (PAO) is a major comorbidity of PPP, frequently affecting the...